GlucoTrack, Inc. (GCTK)
0.9832
+0.15
(+17.47%)
USD |
NASDAQ |
Apr 29, 09:58
GlucoTrack Research and Development Expense (TTM) : 9.813M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 2.943B |
| Accuray, Inc. | 44.10M |
| Alphatec Holdings, Inc. | 75.82M |
| Boston Scientific Corp. | 2.125B |
| Plus Therapeutics, Inc. | 8.379M |